Ameya Precision Engineers manufactures high-accuracy mechanical components like shafts, stems, and valve trims for industrial pump and valve manufacturers, primarily serving international markets.
The company possesses a narrow moat based on high switching costs and technical expertise required for safety-critical valve and pump components. This is corroborated by a healthy average ROCE of 19.6% and long-standing relationships with global engineering majors like Flowserve and Sulzer.
Management has prioritized internal reinvestment, recently acquiring land for expansion and upgrading solar capacity to reduce costs. They maintain a very conservative balance sheet with negligible debt and have opted to retain profits rather than pay dividends to fund future growth.
The investment failed because revenue growth proved to be a vanity metric that masked a fundamental inability to scale profitably. While the company expanded its physical footprint and solar capacity, the negative EPS CAGR observed today eventually culminated in a total margin collapse as the business became a high-overhead commodity shop. The heavy reliance on a single segment (Valves) and a few global majors backfired when those customers insourced production or squeezed pricing, turning the company's 'technical expertise' into a stranded asset with no pricing power to offset rising operational costs.
RichFakir rates Ameya Precision Engineers Ltd's business quality as wonderful — 73/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Ameya Precision Engineers Ltd is trading about 6% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Ameya Precision Engineers Ltd is: Buy candidate. A wonderful business trading below what we think it is worth — so it makes our buy list.
RichFakir's educational estimate of Ameya Precision Engineers Ltd's fair value is about ₹185 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →